On October 14, 2013, Savient Pharmaceuticals, Inc. and its affiliate, Savient Pharma Holdings, Inc. (the “Debtor”), filed voluntary petitions for relief under chapter 11 of title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Court”). These Chapter 11 Cases were assigned to the Honorable Judge Mary F. Walrath and jointly administered under the main case, Savient Pharmaceuticals, Inc., Case No. 13-12680-MFW.
On October 16, 2013, the Court entered an order authorizing the Debtor to retain The Garden City Group, Inc. (“GCG”) as its claims and noticing agent.
On May 19, 2014, the Court entered an order (“Confirmation Order”) confirming the First Amended Plan of Liquidation Pursuant to Chapter 11 of the Bankruptcy Code Proposed by the Debtors (the “Plan”) dated October 14, 2013. The Plan became effective on May 30, 2014. On June 20, 2014, the Court entered an order terminating employment of GCG as claims and noticing agent for the Debtor. Copies of the Plan, Confirmation Order, Notice of Effective Date, and Termination Order are available by clicking the appropriate links on the left.
For further information on the Debtor’s case, please visit the Court’s website at https://ecf.deb.uscourts.gov/, where the official docket can be accessed through the Court’s Case Management/Electronic Case Filing (“CM/ECF”) system. A PACER account is needed to access CM/ECF.